President Donald Trump might be in the middle of the legal challenge of his life, but while that’s happening, he’s also scoring massive victories in the battle against COVID-19, with new developments emerging by the day that finally offer Americans a glimpse of light at the end of the tunnel.
According to Just The News, the Food and Drug Administration made a bombshell announcement on Saturday night in which they indicated that the drug Regeron — which was highly touted by Trump — had been cleared for emergency-use approval.
After Trump emerged healthy as ever following his bout with COVID-19 earlier this year, he was quick to praise Regeneron’s experimental, COVID-19 antibody therapy, even going as far as insisting that it was a “cure” that saved his life.
Shortly after Trump released a Twitter video at the time in which he praised Regeneron, the company behind the promising antibody therapy applied for emergency-use authorization. That request came to fruition on Saturday, as the FDA will allow the drug to be used on adults with mild to moderate COVID-19 cases, as well as children over 12 who are experiencing serious complications.
According to Fox Business, Regeneron is a class of drugs commonly referred to as “antibody cocktails,” with the drug containing a proprietary antibody mixed with the antibodies of those who were previously sick with COVID-19. The antibodies work in concert to attack COVID-19 spike protein to prevent it from taking over healthy cells in the body.
Testing has shown that Regeneron has an impressive success rate if administered in the early diagnosis stage of COVID-19 and/or for those who have a high viral load of the disease.
As far as who will be able to receive the experimental drug, the company has reported that by the end of November, it will have been used by roughly 80,000 patients. By early January, the company expects that 200,000 patients will be using Regeneron, with the numbers growing from there.
Between Regeneron and recent news of Pfizer and Moderna ready to deploy vaccines that have astonishingly high success rates, even if Trump loses the White House, he’s already cementing his legacy as the president who — through programs like Operation Warp Speed — came up with a cure in record-breaking time.